Risk and anxiety: Polyvalence of ethics in high-tech antenatal care

Critical Public Health

Volumn 12, Issue 2, 2002, Pages 119-137

  Helén, Ilpo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; ANXIETY; ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; FINLAND; HUMAN; INFORMED CONSENT; MATERNAL CARE; MEDICAL ETHICS; MEDICINE; OBSTETRIC OPERATION; PREGNANCY; PRENATAL CARE; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; REPRODUCTIVE HEALTH; RESPONSIBILITY; RISK ASSESSMENT; TECHNOLOGY;

EID: 0036316487     PISSN: 09581596     EISSN: None     Source Type: Journal    
DOI: 10.1080/09581590210127361     Document Type: Article

References (112)

1. Anxiety in women with low maternal serum alpha-fetoprotein screening results
2. Chorionic villus sampling and selective termination of a chromosomally abnormal fetus in a triplet pregnancy
3. Downin oireyhtymän seulonta Suomessa
4. Periytyvien häiriöiden intrauteriininen toteaminen
5. Lapsivesitutkimukset suomessa
6. Lapsivesitutkimus sikiödiagnostiikassa
7. Mutaation tunnistamisesta väestön kartoitukseen
8. Geneettiset seulonnat - Osa huomispäivän lääketiedettä
9. Sikiödiagnostiikan päämäärät
10. The history of medical ethics
11. Die soziale konstruktion des risikos-das beispiel pränatal diagnostik
12. A 1 and 6 month follow-up of prenatal diagnosis patients who lost pregnancies
13. The psychological sequelae of abortion for genetic indication
14. The psychological impact of false positive elevations of maternal serum α-fetoprotein
15. From dangerousness to risk
16. de la Uusi genetiikka lääketieteessa
17. de la Disease gene mapping in isolated human populations: The example of Finland
18. Kytkentäa ja kytkentäepätasapaino suomalaisessa tautiperinnössä
19. Genetic technology and reproductive choice: An ethics of autonomy
20. The psychological impact of diagnostic ultrasound
21. Postscript on control societies
22. Attitudes of patients after 'genetic' termination of pregnancy
23. Hyvinvointivaltion muodonmuutos
24. Determinants of altered anxiety after abnormal maternal serum α-fetoprotein screening
25. Psychological aspects of amniocentesis: Anxiety feelings in three different risk groups
26. Norms, discipline and the law
27. Insurance and risk
28. Autonomy, choice, and the new reproductice technologies: The role of informed consent in prenatal genetic diagnosis
29. Stress after amniocentesis for high serum alpha-fetoprotein concentrations
30. Screening for neural-tube defects and maternal anxiety
31. Micro-anatomo politics: Mapping of the Human Genome Project
32. Raskauden ajan seulonnat
33. Elämä, riski ja ahdistus. Tekniikka ja valinnan etiikka sikiödiagnooseissa
34. Prenatal care in Finland: From primary to tertiary health care
35. DNA-based carrier screening in primary healthcare: Screening for aspartylglucosaminuria mutations in maternity care offices
36. Ultrasound scanning in women with raised serum alpha fetoprotein: Long term psychological effect
37. Genetic screening in maternity care: Preventive aims and voluntary choices
38. Ethics of clinical genetics and genetic research: The spirit of profession and trials of suitability from 1970 to 2000
39. DNA-laboratoriosta kliiniseen työhön
40. The Molecular Vision of Life
41. Genomiprojektin ensimmäiset hedelmät kypsyvät
42. Predictive genetic medicine-a new concept of disease
43. The sociology of entrenchment: A cystic fibrosis test for everyone?
44. Die regierung der risiken: Von der eugenik zur genetischen gouvernementalität
45. Prenatal testing and screening: Constructing needs and reinforcing inequities
46. Sequelae and support after termination of pregnancy for fetal malformation
47. Risk: A Sociological Theory
48. Abortion and Politics of Motherhood
49. Existentialism
50. Reducing psychological costs
51. The psychological effects of false-positive results in prenatal screening for fetal abnormality: A prospective study
52. The impact of prenatal screening and diagnostic testing upon cognitions, emotions and behaviour of pregnant women
53. Screening Down syndrome
54. Psychological effects of having amniocentesis: Are these due to the procedure, the risk or the behaviour
55. Anxiety, knowledge and satisfaction in women receiving false positive results on a routine prenatal screening: A randomized controlled trial
56. Ontological politics. A word and some questions
57. Suomalaisen tautiperinnon tulevaisuus
58. Genetic risk and the birth of the somatic individual
59. Sikiön kromosomipoikkeamien seulonta verinäytteestä. Rodunjalostusta vai valinnanvapautta?
60. Who cares for women? Science and love in midwifery today
61. A history lesson: Ultrasound in obstetrics
62. Risk and responsibility
63. Ethics and Human Reproduction. A Feminist Analysis
64. Geenidiagnostiikan uudet ulottuvuudet
65. The new genetics and the politics of public health
66. Counselling genetically 'at-risk': The poetics and politics of 'non-directiveness'
67. Coping with serum screening for Down syndrome when the result is given as a numeric value
68. Artificiality and enlightenment: From sociobiology to biosociality
69. Beyond nature and culture: A note on medicine in the age of molecular biology
70. Psychological reactions to pregnancy loss after prenatal diagnostic testing: Preliminary results
71. Anxiety reduction after chorionic villus sampling and genetic amniocentesis
72. Anxiety during a crisis: Emotional effects of screening for neural tube defects
73. Elämän itsensä politiikka
74. The Tentative Pregnancy. Amniocentesis and the Sexual Politics of Motherhood
75. Liberal governance and prenatal care: Risk and regulation of pregnancy
76. Odottavan äidin perinnöllisyysneuvonta
77. Fragiili X- oireyhtymän seulonta alkuraskauden aikana - Tulokset ja äitien mielipiteet
78. Carrier diagnosis of the fragile X syndrome - A challenge in antenatal clinics
79. Antenatal screening for congenital nephrosis in Finland by maternal serum α-fetoprotein
80. Downin oireyhtymän esiintyminen ja sikiödiagnostiikka Suomessa 1984-88
81. Prenatal Screening in Finland - Availability and Women's Decision-making and Experiences
82. Use of prenatal screening tests in Finland
83. On what grounds do women participate in prenatal screening?
84. Women's decision-making in prenatal screening
85. Women's experiences of prenatal serum screening
86. Seulontatutkimukset ja yhteistyö ätiyshuollossa
87. Seulontatutkimukset ja yhteisty-dso äitiyshuollossa
88. Ultrasound scanning in women with raised serum alpha fetoprotein: Short term psychological effect
89. Recent developments in the government of pregnancy
90. The psychological sequelae of a second trimester termination of pregnancy for fetal abnormality
91. Modern medicine and the 'uncertain body': From corporeality to hyperreality?
92. The notion of risk in Finnish prenatal care: Managing risk mothers and risk pregnancies
93. Suomalainen terveydenhuolto: Jännitteitä ja murroksia
94. Constructing genetic diseases
95. Do women grieve after terminating pregnancies because of fetal anomalies? A controlled investigation